Zispin SolTab 30 mg orodispersible tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

zispin soltab 30 mg orodispersible tablets

merck sharp & dohme ireland (human health) limited - mirtazapine - orodispersible tablet - 30 milligram(s) - other antidepressants; mirtazapine

Zispin 15 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

zispin 15 mg film-coated tablets

organon pharma (ireland) limited - mirtazapine - film-coated tablet - 15 milligram(s) - other antidepressants; mirtazapine

Zispin 30 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

zispin 30 mg film-coated tablets

organon pharma (ireland) limited - mirtazapine - film-coated tablet - 30 milligram(s) - other antidepressants; mirtazapine

Zispin 15 mg film-coated tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

zispin 15 mg film-coated tablets

nv organon - mirtazapine - film-coated tablet - 15 milligram(s) - other antidepressants; mirtazapine

Zispin SolTab 15 mg orodispersible tablets Irland - engelsk - HPRA (Health Products Regulatory Authority)

zispin soltab 15 mg orodispersible tablets

merck sharp & dohme ireland (human health) limited - mirtazapine - orodispersible tablet - 15 milligram(s) - other antidepressants; mirtazapine

MIRTAZAPINE tablet, film coated USA - engelsk - NLM (National Library of Medicine)

mirtazapine tablet, film coated

ncs healthcare of ky, inc dba vangard labs - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the effectiveness of mirtazapine in hospitalized dep

CIPROFLOXACIN TABLETS Canada - engelsk - Health Canada

ciprofloxacin tablets

ranbaxy pharmaceuticals canada inc. - ciprofloxacin (ciprofloxacin hydrochloride) - tablet - 250mg - ciprofloxacin (ciprofloxacin hydrochloride) 250mg - quinolones

CIPROFLOXACIN TABLETS Canada - engelsk - Health Canada

ciprofloxacin tablets

ranbaxy pharmaceuticals canada inc. - ciprofloxacin (ciprofloxacin hydrochloride) - tablet - 500mg - ciprofloxacin (ciprofloxacin hydrochloride) 500mg - quinolones

CIPROFLOXACIN TABLETS Canada - engelsk - Health Canada

ciprofloxacin tablets

ranbaxy pharmaceuticals canada inc. - ciprofloxacin (ciprofloxacin hydrochloride) - tablet - 750mg - ciprofloxacin (ciprofloxacin hydrochloride) 750mg - quinolones